October 10, 2017 05:37 AM EDTUpdated 07:42 AM
People
Financing
China

Ab­bas Hus­sain swings from top GSK phar­ma post to pow­er­house Chi­nese pri­vate eq­ui­ty play­er C-Bridge

John Carroll

Editor & Founder

Near the be­gin­ning of this year Ab­bas Hus­sain an­nounced plans to leave his role as Glax­o­SmithK­line’s phar­ma chief, hand­ing over the job to Luke …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times